NAGE Operating Income Growth
Niagen Bioscience Inc · Operating Income Growth
NAGE Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported-48.32%period ending
NAGE TTM Operating Income YoY % (-4995.32% → -48.32%)
Year-over-year change
High-resolution chart · PNG
NAGE operating income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Income Growth |
|---|---|
| -48.3203% | |
| -16.0934% | |
| 85.0375% | |
| 4,218.5682% | |
| 824.1529% | |
| 403.2783% | |
| 237.9889% | |
| 106.5018% | |
| 73.8201% | |
| 66.0914% | |
| 69.9431% | |
| 69.4444% | |
| 68.903% | |
| 53.1247% | |
| 31.1934% | |
| 19.1752% | |
| -21.9161% | |
| -28.6833% | |
| -36.3604% | |
| -22.9974% | |
| 8.4186% | |
| 25.9976% | |
| 36.5687% | |
| 26.2288% | |
| 21.8075% | |
| 13.0548% | |
| 5.6433% | |
| 8.9878% | |
| -14.4866% | |
| -44.0913% | |
| -102.555% | |
| -246.7045% | |
| -278.6574% | |
| -416.9227% | |
| -636.7372% | |
| -625.7082% | |
| -3,032.6453% | |
| -460.6712% | |
| -3.2058% | |
| 33.5668% | |
| 91.6063% | |
| 81.5366% | |
| 58.8284% | |
| 58.3553% | |
| 47.7419% | |
| 10.6069% | |
| -19.2617% | |
| 9.7168% | |
| 3.8333% | |
| 44.2669% | |
| 62.3042% | |
| 56.839% | |
| 57.4704% | |
| 22.5557% | |
| -47.9664% | |
| -98.2081% | |
| -180.1035% | |
| -247.6786% | |
| -289.8682% | |
| -405.8731% | |
| -779.7004% | |
| -500.9587% | |
| -125.9531% | |
| 12.0504% | |
| 72.103% | |
| 76.5407% | |
| 54.352% | |
| -5.8968% | |
| -203.7269% | |
| -16,509.0464% | |
| -4,995.3155% |